What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
CIK: 0001358331
Total reported value
$369.5M
$369.5M
40 檔
35.9%
During the Q2 2024 filing period, Bruce & Co., Inc. (CIK: 0001358331) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $369.5M across 40 reported positions.
During Q2 2024, Bruce & Co., Inc.'s portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | UHAL-B | U-haul Holding Co-non Voting | Stock-Other | 10.72% | +0.74% | +10.05% | |
| 2 | MRK | Merck & Co., Inc. | Stock-Healthcare | 9.14% | +0.01% | +1.72% | |
| 3 | ABBV | Abbvie Inc | Stock-Healthcare | 9.11% | +0.62% | +17.03% | |
| 4 | NEE | NextEra Energy, Inc. | Stock-Utilities | 7.76% | -0.99% | +13.52% | |
| 5 | ALL | Allstate CORP | Stock-Financials | 6.85% | +0.56% | +2.59% | |
| 6 | DUK | Duke Energy CORP | Stock-Utilities | 6.79% | -0.50% | +0.94% | |
| 7 | CMS | Cms Energy CORP | Stock-Utilities | 6.27% | -0.29% | +1.27% | |
| 8 | T | At&t Inc | Stock-Comm Services | 6.19% | -1.44% | +2.39% | |
| 9 | ABT | Abbott Laboratories | Stock-Healthcare | 5.21% | -0.58% | +1.53% | |
| 10 | IIIN | Insteel Industries Inc | Stock-Other | 3.50% | -0.52% | — | |
| 11 | XEL | Xcel Energy Inc | Stock-Utilities | 3.44% | -0.22% | +1.55% | |
| 12 | AAPL | Apple Inc | Stock-Tech | 2.75% | +0.07% | +13.11% | |
| 13 | PFE | Pfizer Inc | Stock-Healthcare | 2.54% | -0.43% | +2.94% | |
| 14 | AVA | Avista CORP | Stock-Utilities | 2.29% | -0.10% | — | |
| 15 | DAR | Darling Ingredients Inc | Stock-Consumer Staples | 1.81% | -0.33% | — | |
| 16 | BG | Bunge Global SA | Stock-Consumer Staples | 1.76% | -0.53% | — | |
| 17 | UHAL | U-haul Holding Co | Stock-Other | 1.53% | +0.28% | +6.07% | |
| 18 | NEM | Newmont CORP | Stock-Materials | 1.38% | -0.57% | +52.44% | |
| 19 | VALE | Vale S.A. | Stock-Materials | 1.26% | -0.02% | -14.60% | |
| 20 | ✓ | Acorda Theraputics | Stock-Other | 1.15% | — | — | |
| 21 | RLI | Rli CORP | Stock-Financials | 1.04% | -0.03% | +1020.00% | |
| 22 | ADM | Archer-daniels-midland Co | Stock-Consumer Staples | 0.99% | -0.01% | — | |
| 23 | FOCL | Edap Tms SA -adr | Stock-Other | 0.99% | +0.15% | — | |
| 24 | VICR | Vicor CORP | Stock-Tech | 0.76% | +1.94% | +55.56% | |
| 25 | SUPN | Supernus Pharmaceuticals Inc | Stock-Healthcare | 0.72% | +0.41% | — | |
| 26 | SIRIEUR | Sirius Xm Holdings Inc | Stock-Other | 0.52% | +0.08% | — | |
| 27 | ASH | Ashland Inc. | Stock-Materials | 0.47% | +0.03% | — | |
| 28 | ✓ | Lava Therapeutics NV | Stock-Other | 0.46% | — | — | |
| 29 | AXDX 5 12-15-26Bond | Accelerate Diagnostics | Bond | 0.42% | — | +2.50% | |
| 30 | MNKD | Mannkind CORP | Stock-Other | 0.33% | +0.08% | — | |
| 31 | KOD | Kodiak Sciences Inc | Stock-Other | 0.33% | -0.05% | — | |
| 32 | FATE | Fate Therapeutics Inc | Stock-Other | 0.32% | +0.45% | +109.79% | |
| 33 | 1K0 | Igm Biosciences Inc | Stock-Other | 0.23% | — | +53.85% | |
| 34 | OGN | Organon & Co | Stock-Healthcare | 0.21% | — | +0.58% | |
| 35 | VTRS | Viatris Inc | Stock-Healthcare | 0.21% | +0.02% | +1.00% | |
| 36 | CRBU | Caribou Biosciences Inc | Stock-Other | 0.16% | -0.02% | +50.00% | |
| 37 | WEC | Wec Energy Group Inc | Stock-Utilities | 0.12% | -0.01% | — | |
| 38 | MASS | 908 Devices Inc | Stock-Other | 0.12% | +0.04% | — | |
| 39 | PSNL | Personalis Inc | Stock-Other | 0.12% | +0.42% | — | |
| 40 | WBD | Warner Bros Discovery Inc | Stock-Comm Services | 0.03% | — | +11.36% |
According to official SEC Form 13F filings, Bruce & Co., Inc. reported a total U.S. public equity portfolio value of $369.5M across 40 disclosed positions in Q2 2024.
During Q2 2024, Bruce & Co., Inc.'s top holdings by market value included UHAL-B (10.7%)、MRK (9.1%)、ABBV (9.1%). The largest single position, UHAL-B, represented 10.7% of total portfolio value.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including UHAL-B, MRK, ABBV) accounted for 35.9% of total reported equity market value during Q2 2024.
In Q2 2024, Bruce & Co., Inc. made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.